It is important to note that the Food and Drug Administration (FDA) has historically had a bias against cannabis and has been slow to recognize the potential therapeutic benefits of the plant. This is likely due to the longstanding federal prohibition on cannabis, which has made it difficult for researchers to study the plant and for the FDA to regulate it as a medicine.
The cannabis industry presents an array of high-paying job opportunities across various sectors—from finance and…
Recent studies have indicated a notable decrease in prescriptions for anti-anxiety medications, especially benzodiazepines, in…
We’ve assembled a list of fantastic brands and products from around the cannabis universe to…
If there's one thing I've learned from years of covering cannabis politics, it's that weed…
As we wrap up our deep dive into cannabis and exercise, I can't help but…
With Zoap, Cadillac Rainbow, and Blueberry Caviar. The post Leafly Buzz: 12 hot strains to…